Drugs Made In America Acquisition Corp. Ordinary Shares financial statements

드럭스 메이드 인 아메리카 애퀴지션NASDAQ:DMAA · Nasdaq
$10.89+0.00%
2026-10-05 close

Drugs Made In America Acquisition Corp. Ordinary Shares's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was $0M.

Reported results

Drugs Made In America Acquisition Corp. Ordinary Shares notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q